<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Vitamin D supplementation reduces some AT 1 -AA-induced downstream targets implicated in preeclampsia including hypertension</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-11-30">November 30, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Jessica</forename><forename type="middle">L</forename><surname>Faulkner</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Mississippi Medical Center</orgName>
								<address>
									<settlement>Jackson</settlement>
									<region>Mississippi</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lorena</forename><forename type="middle">M</forename><surname>Amaral</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Mississippi Medical Center</orgName>
								<address>
									<settlement>Jackson</settlement>
									<region>Mississippi</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Denise</forename><forename type="middle">C</forename><surname>Cornelius</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Mississippi Medical Center</orgName>
								<address>
									<settlement>Jackson</settlement>
									<region>Mississippi</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mark</forename><forename type="middle">W</forename><surname>Cunningham</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Mississippi Medical Center</orgName>
								<address>
									<settlement>Jackson</settlement>
									<region>Mississippi</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tarek</forename><surname>Ibrahim</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Mississippi Medical Center</orgName>
								<address>
									<settlement>Jackson</settlement>
									<region>Mississippi</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Autumn</forename><surname>Heep</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Mississippi Medical Center</orgName>
								<address>
									<settlement>Jackson</settlement>
									<region>Mississippi</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nathan</forename><surname>Campbell</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Mississippi Medical Center</orgName>
								<address>
									<settlement>Jackson</settlement>
									<region>Mississippi</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nathan</forename><surname>Usry</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Mississippi Medical Center</orgName>
								<address>
									<settlement>Jackson</settlement>
									<region>Mississippi</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kedra</forename><surname>Wallace</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">University of Mississippi Medical Center</orgName>
								<address>
									<settlement>Jackson</settlement>
									<region>Mississipppi</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Florian</forename><surname>Herse</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Experimental and Clinical Research Center</orgName>
								<orgName type="department" key="dep2">Max-Delbrück Center for Molecular Medicine</orgName>
								<orgName type="institution">Charité</orgName>
								<address>
									<addrLine>Campus Buch</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ralf</forename><surname>Dechend</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Experimental and Clinical Research Center</orgName>
								<orgName type="department" key="dep2">Max-Delbrück Center for Molecular Medicine</orgName>
								<orgName type="institution">Charité</orgName>
								<address>
									<addrLine>Campus Buch</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Cardiology and Nephrology</orgName>
								<orgName type="institution">HELIOS Clinic</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Babbette</forename><surname>Lamarca</surname></persName>
							<email>bblamarca@umc.edu</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Pharmacology and Toxicology</orgName>
								<orgName type="institution">University of Mississippi Medical Center</orgName>
								<address>
									<settlement>Jackson</settlement>
									<region>Mississippi</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Obstetrics and Gynecology</orgName>
								<orgName type="institution">University of Mississippi Medical Center</orgName>
								<address>
									<settlement>Jackson</settlement>
									<region>Mississipppi</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department">Depts. of Pharmacology</orgName>
								<orgName type="institution">Center for Excellence in Cardio-vascular and Renal Research</orgName>
								<address>
									<addrLine>Physiology, and Ob/Gyn</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="institution">University of Mississippi Medical Center</orgName>
								<address>
									<postCode>39216</postCode>
									<settlement>Jackson</settlement>
									<region>MS</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Vitamin D supplementation reduces some AT 1 -AA-induced downstream targets implicated in preeclampsia including hypertension</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-11-30">November 30, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">5E4DF70FB0645D5B51B99877A799E13F</idno>
					<idno type="DOI">10.1152/ajpregu.00218.2016</idno>
					<note type="submission">Submitted 23 May 2016; accepted in final form 9 November 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:24+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>to the ANG II type I receptor (AT1-AA) are associated with preeclampsia (PE).</s><s>We found that vitamin D supplementation reduced AT1-AA and blood pressure (MAP) in the RUPP rat model of PE.</s><s>However, it was undetermined whether the decrease in AT1-AA was the mechanism whereby vitamin D lowered MAP or if it were through factors downstream of AT1-AA.</s><s>Uterine artery resistance index, placental ET-1, and soluble FMS-like tyrosine kinase-1 are increased with AT1-AA-induced hypertension and are considered markers of PE in pregnant women.</s><s>Therefore, we hypothesized that vitamin D would reduce PE factors during AT1-AA-induced hypertension and could lower blood pressure in a model of hypertension during pregnancy without PE features.</s><s>Either ANG II (50 ng•kg Ϫ1 •day) or AT1-AA (1:40) was infused from gestational day (GD) 12-19.</s><s>vitamin D2 (VD2, 270 IU/day) or vitamin D3 (VD3, 15 IU/day) was administered orally from GD14 -GD18.</s><s>MAP (mmHg) increased in AT1-AA (121 Ϯ 4) and ANG II (113 Ϯ 1)-infused pregnant rats compared with normal pregnant rats (NP) (101 Ϯ 2) but was lower in AT1-AAϩVD2 (105 Ϯ 2), AT1-AAϩVD3 (109 Ϯ 2), ANG IIϩVD2 (104 Ϯ 4), and ANG IIϩVD3 (104 Ϯ 3).</s><s>VD2 and/or VD3 improved PE features associated with AT1-AA during pregnancy, while ANG II did not induce such features, supporting the hypothesis that AT1-AA induces PE features during pregnancy, and these are improved with vitamin D. In this study, we demonstrate that vitamin D improved many factors associated with PE and reduced blood pressure in a hypertensive model without PE features, indicating that vitamin D could be beneficial for various hypertensive disorders of pregnancy.</s><s>hypertension; inflammation; pregnancy SEVERAL HEMODYNAMIC CHANGES occur in pregnancy to accommodate the required increase in blood flow for sustenance of the fetoplacental unit.</s><s>The renin-angiotensin system (RAS)</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>which contributes to an increase in blood volume and compensatory increase in diastolic preload and cardiac output <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b15">16)</ref>.</s><s>Despite these increases in blood volume, normal pregnant women do not have an increase in blood pressure.</s><s>Compensatory vasorelaxing mechanisms are activated in pregnant women, such as increased nitric oxide bioavailability and a decreased sensitivity to vasoconstrictors, which maintains vascular tension at normal levels <ref type="bibr" target="#b9">(10,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b30">31)</ref>.</s><s>This careful balance of proconstrictive and prorelaxation factors is essential for the maternal vasculature to adapt and ensure adequate blood flow to the growing fetoplacental unit.</s></p><p><s>Preeclampsia (PE) is a hypertensive disorder of pregnancy characterized by vascular dysfunction and abnormal RAS activation <ref type="bibr">(10 -12, 19)</ref>.</s><s>In contrast to normal pregnant women, PE women exhibit increased vasoconstrictive sensitivity to ANG II, resulting in a decrease in vascular compliance and an increase in blood pressure <ref type="bibr" target="#b9">(10,</ref><ref type="bibr" target="#b11">12)</ref>.</s><s>This loss of protection from ANG II-induced vasoconstriction is associated with systemic increases in reactive oxygen species (ROS), vasoconstrictive endothelin-1 (ET-1), and anti-angiogenic soluble FMS-like tyrosine kinase-1 (sFlt-1), which are markers of endothelial dysfunction and PE severity in these patients <ref type="bibr" target="#b10">(11,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b31">32)</ref>.</s><s>Drugs, such as angiotensin II type 1 (AT 1 ) receptor blockers and angiotensin-converting enzyme (ACE) inhibitors are contraindicated in pregnancy; however, a therapeutic agent that reduces ANG II sensitivity in PE patients safely would be expected to alleviate hypertension in these patients.</s></p><p><s>Autoantibodies to the ANG II type 1 receptor (AT 1 -AA) are increased in PE patients, compared with normal pregnant patients, and their levels correlate with the severity of PE and have been suggested as a mechanism whereby such hypersensitivity to ANG II develops in PE <ref type="bibr" target="#b6">(7,</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b37">38)</ref>.</s><s>Infusion of AT 1 -AA into pregnant rats induces many of the characteristics of PE, such as hypertension, sFlt-1, ET-1, and ROS, which are implicated in the development of hypertension and intrauterine growth restriction (IUGR) in PE patients <ref type="bibr" target="#b4">(5,</ref><ref type="bibr" target="#b32">33)</ref>.</s><s>AT 1 -AAs stimulate AT 1 receptor signaling in a similar manner as ANG II to induce increases in blood pressure <ref type="bibr" target="#b4">(5)</ref>.</s><s>However, we are learning that AT 1 -AA also stimulates the AT 1 receptor to induce factors differently from ANG II during pregnancy.</s><s>In fact, in this current study, we compare hypertension and PE factors stimulated by the AT 1 -AA with hypertension and PE factors stimulated by ANG II during pregnancy, as a model of hypertension during pregnancy without PE features.</s><s>We believe that vitamin D can reduce the effect of AT 1 -AA-induced hypertension during pregnancy and could also be beneficial for pregnant hypertensive women with or without PE.</s><s>Vitamin D downregulates RAS activation and improves endothelial function in animal models <ref type="bibr" target="#b27">(28,</ref><ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b44">45)</ref>, and dysregulation of the RAS is a common cause of hypertension.</s><s>Therefore, we used ANG II infusion as a model of hypertension during pregnancy without PE features to compare the beneficial effects of vitamin D supplementation when PE features are induced.</s><s>PE women are at risk for vitamin D deficiency <ref type="bibr" target="#b1">(2,</ref><ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b36">37,</ref><ref type="bibr" target="#b42">43)</ref>.</s><s>Emerging evidence in the literature supports vitamin D supplement regimens to reduce the risk and severity of PE <ref type="bibr" target="#b3">(4,</ref><ref type="bibr" target="#b17">18)</ref>.</s><s>A previous study by our laboratory demonstrated that vitamin D supplementation in the reduced uterine perfusion pressure (RUPP) rat model of PE reduces production of AT 1 -AA, sFlt-1, ET-1, and blood pressure <ref type="bibr" target="#b7">(8)</ref>.</s><s>Collectively, these data suggest that vitamin D reduces symptoms of PE.</s><s>However, it is unknown whether decreased production of AT 1 -AA in the RUPP model was the primary mechanism via which sFlt-1, ET-1, and blood pressure were reduced.</s><s>Therefore, we sought to determine whether vitamin D reduces factors associated with PE in response to AT 1 -AA but also hypertension without PE features during pregnancy.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head><p><s>Procedures involving animals were performed in accordance with the National Institutes of Health "Guidelines for the Care and Use of Laboratory Animals" and were approved by the Institutional Animal Care and Use Committee of the University of Mississippi Medical Center.</s><s>Animals used for experiment were Ͼ250 g timed-pregnant Sprague-Dawley rats (Harlan, Indianapolis, IN) that were housed under a 12:12-h light-dark cycle.</s></p><p><s>Vitamin D administration to AT 1-AA-and ANG II-infused rats.</s><s>AT1-AA was purified using a previously described method <ref type="bibr" target="#b21">(22)</ref>.</s><s>Briefly, total IgG from serum of RUPP rats was purified, and AT1-AA was extracted from IgG by column purification using an epitope binding site.</s><s>Pregnant rats were implanted with osmotic minipumps (model 2002; Alzet Scientific, Palo Alto, CA) containing either ANG II (50 ng•kg Ϫ1 •min Ϫ1 in saline) or AT1-AA (1:40 in saline) on gestational days (GD) 12-19, as previously described <ref type="bibr" target="#b6">(7,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b35">36)</ref>.</s><s>Groups of ANG II-or AT 1-AA-infused rats were treated with either 270 IU of vitamin D2 (VD2) (County Line Pharmaceuticals, Brookfield, WI) or 15 IU of vitamin D3 (VD3) (Enfamil, Glenview, IL) by daily oral gavage on GD14 -18, as previously described <ref type="bibr" target="#b7">(8)</ref>.</s><s>Numbers of animals per group are as follows: NP: 19, NPϩVD2: 5, NPϩVD3: 4, ANG II: 15, ANG IIϩVD2: 9, ANG IIϩVD3: 7, AT 1-AA: 5, AT1-AAϩVD2: 7, and AT1-AAϩVD3: 6.</s><s>On GD18, animals were implanted with indwelling carotid catheters that were exteriorized after being tunneled under the skin and through the back of the neck.</s><s>Blood pressure was measured in a conscious state via pressure transducer with an acclimation time of 30 min and reading time of 30 min (Cobe II Transducer CDX Sema, Birmingham, AL) on GD19 followed by the weighing of pups and placentas and the collection of tissues and blood for analysis.</s></p><p><s>Assessment of uterine artery resistance index.</s><s>On GD18, uterine artery resistance index (UARI) of rats was measured by Doppler sonography.</s><s>Rats were anesthetized by isoflurane anesthesia and fixed on the platform of a Vevo 770 unit (VisualSonics, Toronto, ON, Canada) with a 30-Hz transducer, model no.</s><s>710B.</s><s>Doppler velocimetry measurements were taken on uterine arteries, and 1 or 2 measurements in a placenta of each uterine horn were imaged (total of 2-4 measurements for both left and right horn combined/animal).</s><s>The waveforms representing the peak systolic velocity (PSV) and the end-diastolic flow velocity (EDV) were captured, and the velocities were measured.</s><s>Three waveforms were measured per frame.</s><s>The equation UARI ϭ (PSV Ϫ EDV)/PSV was used, as is used in clinical settings.</s></p><p><s>Placental and renal cortical preproendothelin-1 mRNA levels.</s><s>Quantitative real-time PCR (qRT-PCR) was utilized to determine tissue preproendothelin-1 (PPET) levels.</s><s>Placenta and renal cortex tissues were isolated and quickly frozen in liquid nitrogen.</s><s>The tissues were then stored at Ϫ80°C.</s><s>Total RNA was extracted from the tissues using the RNeasy Protect mini kit (Qiagen, Germantown, MD) and was performed according to the manufacturer's instructions.</s><s>cDNA was synthesized from 1 g total RNA using the iScript cDNA synthesis kit (Bio-Rad, Hercules, CA).</s><s>qRT-PCR was performed using iQ SYBR Green Supermix (Bio-Rad) and measured for fluorescence on a CFX96 Touch Real-Time PCR Detection System (Bio-Rad).</s><s>The primer sequences provided by Life Technologies (forward: 5=-ctaggtctaagcgatccttg-3=, reverse: 5=-tctttgtctgcttggc-3=) were used for PPET, as previously described <ref type="bibr" target="#b40">(41)</ref>.</s><s>Levels of mRNA were calculated using the mathematical formula for 2 Ϫ⌬⌬Ct (2avg•Ct gene of interest Ϫ avg Ct ␤-actin), as recommended by Applied Biosystems (Applied Biosystems User Bulletin, no. 2, 1997) and expressed as a fold change to NP rats for all experimental rat groups.</s></p><p><s>Measurement of plasma sFlt-1 levels by ELISA.</s><s>Circulating sFlt-1 levels were measured by ELISA (R&amp;D Systems, Minneapolis, MN).</s><s>Sensitivity for the ELISA was 15.2 pg/ml, and the assay range was 31.3-4,000</s><s>pg/ml.</s></p><p><s>Analysis of circulating reactive oxygen species by 8-isoprostane measurement.</s><s>Oxidative stress was assessed by measuring plasma 8-isoprostane levels using an ELISA (Cayman Chemical, Ann Arbor, MI). Assay range for this ELISA was 0.8 -500 pg/ml.</s><s>Where necessary, samples were diluted to ensure values were within the standard curve range.</s></p><p><s>Statistical analysis.</s><s>Data were expressed as means Ϯ SE.</s><s>The significance of difference in mean values were performed by one-way ANOVA with Bonferroni multiple-comparison post hoc test and/or by an unpaired standard t-test for two groups.</s><s>P Ͻ 0.05 was considered to be significant.</s><s>The commercial program GraphPad Prism 5 (GraphPad Software, La Jolla, CA) was used for data analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p><s>Vitamin D supplementation reduces mean arterial pressure in response to ANG II or AT 1 -AA.</s><s>Vitamin D 2 (NPϩVD2) and D 3 (NPϩVD3) supplementation into normal pregnant rats (NP) had no significant effect on mean arterial pressure (MAP) in NP rats (Fig. <ref type="figure" target="#fig_0">1A</ref>).</s><s>AT 1 -AA infusion into pregnant rats significantly increased blood pressure to 121 Ϯ 4 mmHg (P Ͻ 0.05, unpaired t-test) compared with NP (101 Ϯ 2 mmHg).</s><s>Both VD2 and VD3 treatment significantly lowered MAP to 105 Ϯ 2 and 109 Ϯ 2 mmHg (P Ͻ 0.05, unpaired t-test) in AT 1 -AA-infused rats, respectively.</s><s>ANG II infusion increased blood pressure to 113 Ϯ 1 mmHg (P Ͻ 0.05, unpaired t-test) in pregnant rats and both VD2 (104 Ϯ 4 mmHg, P Ͻ 0.05, unpaired t-test) and VD3 (104 Ϯ 3 mmHg, P Ͻ 0.05, unpaired t-test) reduced blood pressure relative to ANG II alone.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Effects of vitamin D on intrauterine growth restriction in normal pregnant, AT 1 -AA, or ANG II-infused pregnant rats.</head><p><s>Although previous studies from the Xia laboratory infused AT 1 -AA and observed IUGR in pregnant mice, we do not commonly see this PE feature in our AT 1 -AA infused rats <ref type="bibr" target="#b16">(17)</ref>.</s><s>This may be due to differences in concentration or route of administration between the protocols of our laboratory and those of the Xia laboratory.</s><s>Nevertheless, we feel that examining pup or placental effects in response to an intervention such as vitamin D is important in evaluating the safety of vitamin D in our AT 1 -AA and ANG II-infused rats.</s><s>Neither AT 1 -AA nor ANG II infusion into pregnant rats significantly affected pup weights in our study.</s><s>Although pup weights were not significantly less in AT 1 -AA or ANGII infusion compared to NP, VD3 treatment did improve pup weight of AT 1 -AA infused compared to AT 1 -AA alone.</s><s>NP rat placental weights did not differ from those of AT 1 -AA-or ANG II-infused pregnant rats (Fig. <ref type="figure" target="#fig_0">1C</ref>).</s><s>Vitamin D did not impact placental weights in ANG II-infused rats.</s><s>Placental weight was reduced in AT 1 -AAϩVD2 rats; however, VD3 had no effect.</s></p><p><s>Placental efficiency, as defined by placenta:fetal weight ratio, was unchanged in AT 1 -AA and ANG II rats compared with NP (Fig. <ref type="figure" target="#fig_0">1D</ref>).</s><s>VD2 treatment did not alter this ratio in NP, AT 1 -AA-infused, or ANG II-infused rats.</s><s>NPϩVD3, AT 1 -AAϩVD3, or ANG IIϩVD3 rats did not have an altered placenta:fetal weight ratio compared with their untreated counterparts.</s><s>Most importantly, these data indicate that vitamin D did not have adverse outcomes on fetal growth or survival.</s></p><p><s>Uterine artery resistance index is increased in AT 1 -AAinfused rats and reduced with vitamin D treatment.</s><s>Pregnant rats with AT 1 -AA exhibit increased uterine artery resistance index (UARI), defined by (PSV Ϫ EDV)/PSV, on GD18 compared with NP rats (0.569 Ϯ 0.014 vs. 0.407 Ϯ 0.018, respectively, P Ͻ 0.05, unpaired t-test) (Fig. <ref type="figure" target="#fig_0">1E</ref>).</s><s>Neither VD2 nor VD3 supplementation in NP rats (0.432 Ϯ 0.027 and 0.451 Ϯ 0.028, respectively) had an effect on UARI compared with NP rats.</s><s>Although VD3 supplementation reduced UARI in AT 1 -AA-infused rats, VD2 did not have a significant effect (0.487 Ϯ 0.031 and 0.511 Ϯ 0.031, respectively, P Ͻ 0.05, unpaired t-test).</s></p><p><s>sFlt-1 levels are reduced in AT 1 -AA-infused pregnant rats treated with vitamin D. As shown in previous studies, AT <ref type="bibr" target="#b0">1</ref> -AA infusion into pregnant rats (714.6 Ϯ 188.5 pg/ml) increased circulating sFlt-1 levels compared with NP rats (93.9 Ϯ 12.1 pg/ml, P Ͻ 0.05, unpaired t-test and one-way ANOVA).</s><s>(Fig. <ref type="figure" target="#fig_1">2A</ref>).</s><s>Importantly, both VD2 (77.1 Ϯ 15.5 pg/ml, P Ͻ 0.05, unpaired t-test and one-way ANOVA) and VD3 (195.1 Ϯ 87.0 pg/ml, P Ͻ 0.05, unpaired t-test and one-way ANOVA) drastically reduced sFlt-1 in AT 1 -AA infused rats.</s><s>ANG II infusion into pregnant rats did not alter sFlt-1 (60.4 Ϯ 6.3 pg/ml) levels compared with NP.</s><s>However, VD2 and VD3 did significantly reduce sFlt-1 in ANG II-infused rats (22.0 Ϯ 8.2 and 41.6 Ϯ 10.3 pg/ml, respectively, P Ͻ 0.05, unpaired t-test) to a level below that of NP rats.</s></p><p><s>Placental and renal cortical ET-1 mRNA levels with vitamin D supplementation in both AT 1 -AA-and ANG II-infused pregnant rats.</s><s>We measured ET-1 expression by real-time PCR of its precursor, preproendothelin-1 (PPET) in placenta and renal cortex and normalized groups to NP. Placental PPET increased in AT 1 -AA-infused pregnant rats (18.1 Ϯ 2.9-fold change, P Ͻ 0.05, unpaired t-test and one-way ANOVA) (Fig. <ref type="figure" target="#fig_1">2B</ref>) but was significantly reduced with VD2 (4.</s><s>Effects of vitamin D on plasma isoprostane levels in AT 1 -AA-infused rats treated with vitamin D. We assessed levels of an indicator of reactive oxygen species, 8-isoprostanes, in plasma.</s><s>AT 1 -AA-infused pregnant rats had increased isoprostane (1633 Ϯ 179 pg/ml, P Ͻ 0.05, unpaired t-test and oneway ANOVA) compared with NP rats (634 Ϯ 197 pg/ml) (Fig. <ref type="figure" target="#fig_1">2D</ref>).</s><s>VD2 and VD3 supplementation in AT 1 -AA-infused rats reduced the isoprostane levels (436 Ϯ 81 and 752 Ϯ 94 pg/ml, respectively, P Ͻ 0.05, unpaired t-test and one-way ANOVA).</s><s>ANG II rats had significantly higher isoprostane levels compared with NP (1505 Ϯ 233 pg/ml, P Ͻ 0.05, unpaired t-test).</s><s>However, they did not change in ANG IIϩVD2 (1682 Ϯ 248 pg/ml) or ANG IIϩVD3 (1714 Ϯ 247 pg/ml).</s><s>These data indicate that although the extent to which isoprostanes were increased was similar in AT 1 -AA and ANG II-infused rats, the mechanism by which vitamin D reduced isoprostanes was specific to AT 1 -AA-induced mechanisms.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>PE is associated with elevated ET-1, ROS, sFlt-1, AT 1 -AA, as well as increased UARI, IUGR, and hypertension during pregnancy.</s><s>Over the years, we and others have shown that infusion of AT 1 -AA induces all of these factors, when infused into pregnant rodents <ref type="bibr" target="#b4">(5,</ref><ref type="bibr" target="#b16">17,</ref><ref type="bibr" target="#b32">33)</ref>.</s><s>We have recently published that VD2 or VD3 supplementation to the RUPP rat model of PE significantly lowered blood pressure and circulating factors thought to play an important role in the disease, such as CD4ϩ T cells, IL-6, sFlt-1, ET-1, and AT 1 -AA <ref type="bibr" target="#b7">(8)</ref>.</s><s>However, whether reduction of AT 1 -AA levels by vitamin D in RUPP rats was the central mechanism via which blood pressure and such factors were reduced was not investigated.</s><s>AT 1 -AA has been shown to induce PE characteristics independent of placental ischemia.</s><s>Although ANG II infusion increased blood pressure, renal ET-1, and ROS during pregnancy, it does not stimulate sFlt-1 and other PE features <ref type="bibr" target="#b4">(5)</ref>.</s><s>Therefore, ANG II infusion into pregnant rats was used as a model to study hypertension during pregnancy without PE features, which would be comparable to gestational or chronic hypertension in pregnancy.</s><s>Therefore, the purpose of the present study was to determine whether vitamin D reduced blood pressure and factors associated with PE induced by AT 1 -AA and improved blood pressure in ANG II-treated rats as an example of hypertension without complicating factors observed in PE.</s><s>As gestational hypertension is a significant risk factor for PE, reductions in blood pressure in this model could implicate vitamin D for prevention and/or treatment of PE and other disease states of pregnancy not complicated by PE.</s><s>Ultimately, the outcome of these studies sheds light on the efficacy of vitamin D to improve pregnancy outcomes as part of a prenatal regimen.</s></p><p><s>Emerging studies in both the clinical population and in rodent models of PE indicate that vitamin D may reduce the immune pathogenesis of PE and improve blood pressure <ref type="bibr" target="#b3">(4,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b17">18)</ref>.</s><s>Vitamin D has been associated with improvement of endothelial function in rodent models and in the vasculature ex vivo <ref type="bibr" target="#b27">(28,</ref><ref type="bibr" target="#b43">44)</ref>.</s><s>In this study, we show that vitamin D supplementation to hypertensive pregnant rats with AT 1 receptor activation by either ANG II or AT 1 -AA, safely improves blood pressure without harming fetal weight.</s><s>Furthermore, we found that markers of PE, ROS, ET-1, and sFlt-1 were reduced in AT 1 -AA-infused rats with vitamin D supplementation.</s><s>In addition, we observed in our AT 1 -AA-infused rats that vitamin D 2 and vitamin D 3 are not identical with regard to effects on blood pressure, which may be attributable to differences in efficacy of the two isoforms of the compound in the rat <ref type="bibr" target="#b7">(8)</ref>.</s><s>In comparison to AT 1 -AA-infused rats, ANG II-infused rats did not have an increase in sFlt-1 or placental ET-1.</s><s>In addition, ROS levels were not altered with vitamin D supplementation, indicating that although both AT 1 -AA and ANG II activate the AT 1 receptor to increase blood pressure, the downstream pathways activated during pregnancy differ.</s><s>Furthermore, it is possible that during hypertension without PE features, i.e., elevated AT 1 -AA levels, ANG II does not have as profound of an effect to activate downstream PE mechanisms during pregnancy.</s><s>Nevertheless, in either ANG II-or AT 1 -AA-induced hypertensive pregnancy, vitamin D safely lowered the maternal hypertensive response.</s></p><p><s>Vitamin D has a provascular effect in models of endothelial dysfunction, which may be attributed to reductions in ROS <ref type="bibr" target="#b43">(44)</ref>.</s><s>In the present study, we observed a reduction in a marker of systemic ROS, 8-isoprostanes, in our AT 1 -AA-infused rats treated with vitamin D. In addition, our findings in the present study show that sFlt-1 induced by AT 1 -AA infusion was attenuated by either VD2 or VD3 supplementation.</s><s>sFlt-1 has an important role in the pathogenesis of PE and is directly correlated with PE severity in human patients <ref type="bibr" target="#b24">(25,</ref><ref type="bibr" target="#b39">40)</ref>.</s><s>Studies have demonstrated that sFlt-1 infusion into pregnant rats and mice induces many of the characteristics of PE, including increases in blood pressure and ET-1 <ref type="bibr" target="#b25">(26,</ref><ref type="bibr" target="#b26">27)</ref>.</s><s>Although the exact mechanism via which AT 1 -AA induces increases in sFlt-1 levels remains unclear, these data demonstrate that vitamin D can alter this mechanism as a method to improve blood pressure during high levels of AT 1 -AA, as in the case of PE.</s><s>Importantly, and indicating the specificity for AT 1 -AA during PE, sFlt-1 is not elevated in ANG II-induced hypertensive pregnant rats in this study.</s></p><p><s>ET-1 is a potent vasoconstrictor peptide and is increased in both human preeclamptic patients and in rodent models of PE <ref type="bibr" target="#b0">(1,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b28">29,</ref><ref type="bibr" target="#b34">35)</ref>.</s><s>ET-1 is induced in response to AT 1 receptor activation by ANG II and by AT 1 -AA <ref type="bibr" target="#b4">(5,</ref><ref type="bibr" target="#b33">34)</ref>.</s><s>It has been proposed that AT 1 -AA-induced ET-1 contributes to the systemic endothelial dysfunction seen in preeclamptic patients, which is characterized by increases in the UARI <ref type="bibr" target="#b19">(20,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b38">39)</ref>.</s><s>Interestingly, studies have demonstrated that vitamin D increases the production of ET-1 in some cell types <ref type="bibr" target="#b41">(42)</ref>.</s><s>In fact, we observed that both VD2 and VD3 increased ET-1 expression in the renal cortices of our normal pregnant rats.</s><s>In the kidney, vasodilatory endothelin receptor type B (ET B ) receptors are prevalent and promote sodium excretion and a lowering of blood pressure.</s><s>It is possible that vitamin D did not increase blood pressure in our normal pregnant rats despite this increase in renal cortical ET-1 expression due to ET B receptor activation; however, investigation into this mechanism was beyond the scope of the current study.</s><s>Clinical studies indicate that vitamin D supplementation reduces plasma ET-1 levels and that this is associated with an improvement of factors associated with endothelial dysfunction in pregnancy such as sFlt-1 and ROS, implying that inhibition of ET-1 by vitamin D was upstream of direct transcriptional regulation of ET-1 <ref type="bibr" target="#b35">(36,</ref><ref type="bibr" target="#b43">44)</ref>.</s><s>In our current study, we found that both ANG II and AT 1 -AA-induced ET-1 in the renal cortex, most likely a mechanism contributing to the hypertension in each model.</s><s>VD2 decreased ET-1 in the renal cortex in each model while VD3 seemed to have no effect.</s><s>These data indicate that the AT 1 -dependent mechanism via which AT 1 -AA and ANG II activate ET-1 transcription in the renal cortex is similar and, furthermore, that the mechanism via which VD2 and VD3 interact with that mechanism is also similar.</s><s>In contrast, only AT 1 -AA stimulated placental ET-1, and profoundly so, indicating an important difference between AT 1 -AA and ANG II-stimulated pathways during hypertensive pregnancy.</s><s>Both VD2 and VD3 reduced placental ET-1, while only VD2 was able to significantly reduce UARI, which indicates that reductions in both placental and renal cortex ET-1 production contributed to reduce UARI in our AT 1 -AA-infused rats.</s></p><p><s>The stimuli by which placental ischemia leads to production of AT 1 -AA have been only partially elucidated.</s><s>What has been well established is that AT 1 -AA activates the AT 1 receptor and stimulates many downstream effects similar to ANG II, such as vasoconstriction and hypertension <ref type="bibr" target="#b4">(5)</ref>.</s><s>However, there are many downstream mechanisms of AT 1 receptor activation by AT 1 -AA that differ from those of ANG II.</s><s>AT 1 -AA infusion into pregnant rats increased sFlt-1 and ET-1, whereas ANG II had no effect on sFlt-1 or placental ET-1 levels.</s><s>Both ANG II and AT 1 -AA induce increases in systemic ROS; however, this was decreased with vitamin D treatment during AT 1 -AA-induced hypertension only in the placenta <ref type="bibr" target="#b4">(5)</ref>.</s><s>VD2 and VD3 were able to effectively reduce sFlt-1 and placental ET-1 when AT 1 -AA was elevated.</s><s>Importantly, these reductions also occurred with reduced blood pressure without affecting fetal outcomes.</s></p><p><s>Collectively, these data indicate that vitamin D supplementation may be beneficial not only in women with established PE and the presence of AT 1 -AA, but those with hypertension not complicated by PE or AT 1 -AA as depicted in our ANG II infusion model.</s><s>Therefore, we conclude that VD2 or VD3 could be an important, inexpensive, and widely available supplement that could be added to the prevention and treatment strategies for pregnant hypertensive women, whether or not they develop PE features.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Perspectives and Significance</head><p><s>In this study, we have shown that vitamin D reduces some factors that are associated with pathophysiology of PE in AT 1 -AA-infused rats.</s><s>Furthermore, we show that it is safe for blood pressure management in hypertensive pregnancies in the absence of PE.</s><s>Moreover, we also demonstrated that vitamin D supplementation into NP rats did not adversely affect fetal growth, survival, or uterine artery resistance and, therefore, this study indicates that vitamin D may be a potential therapeutic to prevent increases in sFlt-1, ET-1, ROS, and blood pressure in PE, and hypertensive pregnancies at risk of PE.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc><div><p><s>Fig. 1.</s><s>A: blood pressures were significantly increased in both ANG II-and AT1-AA-infused rats compared with NP.</s><s>Neither VD2 nor VD3 treatment affected blood pressure in NP rats.</s><s>Both VD2 and VD3 significantly reduced blood pressure in ANG II-and AT1-AA-infused rats.</s><s>AT1-AA infusion increased blood pressure above levels observed in ANG II-infused rats (n: NP ϭ 19, NPϩVD2 ϭ 6, NPϩVD3 ϭ 5, ANG II ϭ 14, ANG IIϩVD2 ϭ 9, ANG IIϩVD3 ϭ 7, AT1-AA ϭ 6, AT1-AAϩVD2 ϭ 8, and AT1-AAϩVD3 ϭ 6).</s><s>Comparisons by unpaired t-test.</s><s>B: there were no changes in pup weight in ANG II or AT1-AA rats compared with NP.</s><s>Although pup weights were not significantly less in AT1-AA or ANGII infusion compared to NP, VD3 treatment did improve pup weight of AT1-AA infused compared to AT1-AA alone.</s><s>Comparisons by unpaired t-test and one-way ANOVA.</s><s>C: placental weights did not differ in ANG II-or AT1-AA-infused rats compared with NP.</s><s>VD2 did reduce placental weight in AT1-AA-infused rats.</s><s>No other groups treated with VD2 or VD3 had significantly altered placental weight compared with their untreated counterparts (n: NP ϭ 13, NPϩVD2 ϭ 5, NPϩVD3 ϭ 4, ANG II ϭ 15, ANG IIϩVD2 ϭ 9, ANG IIϩVD3 ϭ 7, AT1-AA ϭ 6, AT1-AAϩVD2 ϭ 7, and AT1-AAϩVD3 ϭ 6).</s><s>Comparisons by unpaired t-test.</s><s>D: placental efficiency, defined as placenta:fetal weight ratio, was not changed with ANG II or AT1-AA infusion compared with NP rats.</s><s>In addition, neither VD2 nor VD3 affected placenta:fetal weight ratio in either ANG II-or AT1-AA-infused pregnant rats (n: NP ϭ 13, NPϩVD2 ϭ 5, NPϩVD3 ϭ 4, ANG II ϭ 15, ANG IIϩVD2 ϭ 9, ANG IIϩVD3 ϭ 7, AT1-AA ϭ 6, AT1-AAϩVD2 ϭ 7, and AT1-AAϩVD3 ϭ 6).</s><s>Comparisons by unpaired t-test and one-way ANOVA.</s><s>E: uterine artery resistance index (UARI) increased significantly in AT1-AA-infused rats compared with NP.</s><s>Vitamin D treatment in NP rats did not alter UARI.</s><s>Resistance was significantly decreased in AT1-AAϩVD3 rats but did not dignificantly change in AT1-AAϩVD2 rats (n: NP ϭ 5, NPϩVD2 ϭ 4, NPϩVD3 ϭ 3, AT1-AA ϭ 6, AT1-AAϩVD2 ϭ 6, and AT1-AAϩVD3 ϭ 4).</s><s>Comparisons by unpaired t-test.</s><s>*P Ͻ 0.05 vs. NP, ⌽P Ͻ 0.05 vs. ANG II-infused, P Ͻ 0.05 vs. AT1-AA-infused.</s></p></div></figDesc><graphic coords="3,66.36,379.78,179.82,83.09" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 .</head><label>2</label><figDesc><div><p><s>Fig.2.</s><s>A: plasma sFlt-1 levels were significantly increased in AT1-AA-infused rats.</s><s>sFlt-1 was significantly reduced in AT1-AA-infused rats treated with either VD2 or VD3.</s><s>ANG II infusion into pregnant rats did not alter sFlt-1 levels.</s><s>VD2 did reduce sFlt-1 levels in ANG II-infused rats, but VD3 had no effect.</s><s>Neither VD2 nor VD3 affected sFlt-1 levels in NP rats(n: NP ϭ 7, NPϩVD2 ϭ 3, NPϩVD3 ϭ 4, ANG II ϭ 4, ANG IIϩVD2 ϭ 4, ANG IIϩVD3 ϭ 4, AT1-AA ϭ 6, AT1-AAϩVD2 ϭ 6, and AT1-AAϩVD3 ϭ 6).</s><s>Comparisons by unpaired t-test and one-way ANOVA.</s><s>B: placental preproendothelin-1 (PPET) was measured by real-time PCR and normalized to NP level.</s><s>Placental PPET did not change with VD2 or VD3 treatment in NP rats.</s><s>ANG II did not significantly increase placental PPET expression, and Vitamin D did not have an effect in ANG II-infused rats.</s><s>AT1-AA infusion significantly increased placental PPET expression, and both VD2 and VD3 significantly reduced PPET (n: NP ϭ 4, NPϩVD2 ϭ 3, NPϩVD3 ϭ 3, ANG II ϭ 5, ANG IIϩVD2 ϭ 5, ANG IIϩVD3 ϭ 5, AT1-AA ϭ 4, AT1-AAϩVD2 ϭ 4, and AT1-AAϩVD3 ϭ 4).</s><s>Comparisons were made by unpaired t-test and one-way ANOVA.</s><s>C: renal cortex expression of PPET was significantly increased in both ANG II-and AT1-AA-infused pregnant rats.</s><s>VD2 modestly decreased renal cortex PPET in ANG II-and AT1-AA-infused rats; however this did not reach significance.</s><s>VD3 did not alter PPET in the renal cortices of ANG II-or AT1-AA-infused pregnant rats.</s><s>VD2 and VD3 administration to NP rats significantly increased PPET expression in renal cortices (n: NP ϭ 8, NPϩVD2 ϭ 5, NPϩVD3 ϭ 3, ANG II ϭ 4, ANG IIϩVD2 ϭ 6, ANG IIϩVD3 ϭ 5, AT1-AA ϭ 5, AT1-AAϩVD2 ϭ 4, AT1-AAϩVD3 ϭ 3).</s><s>Comparisons were made by unpaired t-test.</s><s>D: 8-isoprostanes were measured in plasma.</s><s>Isoprostanes did not change with Vitamin D treatment in NP rats.</s><s>Isoprostanes were significantly increased in AT1-AA-infused rats and significantly decreased with VD2 and VD3-treated AT1-AA rats.</s><s>ANG II rats had significantly increased isoprostanes compared with NP rats; however, neither VD2 nor VD3 affected isoprostane levels in ANG II rats (n: NP ϭ 5, NPϩVD2 ϭ 4, NPϩVD3 ϭ 4, ANG II ϭ 5, ANGIIϩVD2 ϭ 5, ANG IIϩVD3 ϭ 5, AT1-AA ϭ 5, AT1-AAϩVD2 ϭ 5, and AT1-AAϩVD3 ϭ 5).</s><s>Comparisons were made by unpaired t-test and one-way ANOVA.</s><s>*P Ͻ 0.05 vs. NP, ⌽P Ͻ 0.05 vs. ANG II-infused, P Ͻ 0.05 vs. AT1-AA-infused.</s></p></div></figDesc><graphic coords="4,324.06,479.50,235.02,90.29" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">AJP-Regul Integr Comp Physiol • doi:10.1152/ajpregu.00218.2016 • www.ajpregu.org Downloaded from journals.physiology.org/journal/ajpregu (176.172.000.127) on May 17, 2022.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>GRANTS</head><p><s>This work was supported by National Institutes of Health Grants HL-105324, HL-124715, HL-78147, HL-51971, and HD-067541.</s><s>R. Dechend is supported by the German Research Foundation (DFG Grant DE 631/9-1).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCLOSURES</head><p><s>No conflicts of interest, financial or otherwise, are declared by the authors.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" />			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Endothelin type a receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>Alexander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Rinewalt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Cockrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Massey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Granger</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.HYP.37.2.485</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="485" to="489" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Haeri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Camargo</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Espinola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Stuebe</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2010-0996</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="5105" to="5109" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Platelet angiotensin II binding and plasma renin concentration, plasma renin substrate and plasma angiotensin II in human pregnancy</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Broughton Pipkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Symonds</surname></persName>
		</author>
		<idno type="DOI">10.1042/cs0790403</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Sci (Lond)</title>
		<imprint>
			<biblScope unit="volume">79</biblScope>
			<biblScope unit="page" from="403" to="408" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Maternal vitamin D deficiency increases the risk of preeclampsia</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Bodnar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Catov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">N</forename><surname>Simhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Holick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Powers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Roberts</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2007-0718</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="3517" to="3522" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy</title>
		<author>
			<persName><forename type="first">J</forename><surname>Brewer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wallace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wallukat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Moseley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Herse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dechend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Martin</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lamarca</surname></persName>
		</author>
		<idno type="DOI">10.1161/HYPERTENSIONAHA.113.01648</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="886" to="892" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Sodium excretion in normal and hypertensive pregnancy: a prospective study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Gallery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Ross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Esber</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0002-9378%2888%2980071-1</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="297" to="307" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Vitamin D supplementation suppresses hypoxia-stimulated placental cytokine secretion, hypertension and CD4 ϩ T cell stimulation in response to placental ischemia</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Darby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wallace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cornelius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Chatman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Mosely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Purser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Owens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Lamarca</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med J Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page">1012</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Vitamin D supplementation improves pathophysiology in a rat model of preeclampsia</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Faulkner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Cornelius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Amaral</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Harmon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Cunningham</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Darby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ibrahim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Herse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wallukat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dechend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Lamarca</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajpregu.00388.2015</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Regul Integr Comp Physiol</title>
		<imprint>
			<biblScope unit="volume">310</biblScope>
			<biblScope unit="page" from="R346" to="R354" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Plasma 25-hydroxyvitamin D levels and risk of incident hypertension</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Forman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Giovannucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Holmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Bischoff-Ferrari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Tworoger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Willett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Curhan</surname></persName>
		</author>
		<idno type="DOI">10.1161/HYPERTENSIONAHA.107.087288</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="1063" to="1069" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">A study of angiotensin II pressor response throughout primigravid pregnancy</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Gant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Daley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Whalley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Macdonald</surname></persName>
		</author>
		<idno type="DOI">10.1172/JCI107462</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="2682" to="2689" />
			<date type="published" when="1973">1973</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Gilbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Ryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Lamarca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sedeek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Granger</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajpheart.01113.2007</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Heart Circ Physiol</title>
		<imprint>
			<biblScope unit="volume">294</biblScope>
			<biblScope unit="page" from="H541" to="H550" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Angiotensin II levels in hypertensive and normotensive pregnancies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hanssens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Keirse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Spitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Van Assche</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1471-0528.1991.tb13361.x</idno>
	</analytic>
	<monogr>
		<title level="j">Br J Obstet Gynaecol</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="155" to="161" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Effect of treatment of vitamin D deficiency and insufficiency during pregnancy on fetal growth indices and maternal weight gain: a randomized clinical trial</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hashemipour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ziaee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Javadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Movahed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Elmizadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Javadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lalooha</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejogrb.2013.10.010</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Obstet Gynecol Reprod Biol</title>
		<imprint>
			<biblScope unit="volume">172</biblScope>
			<biblScope unit="page" from="15" to="19" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women</title>
		<author>
			<persName><forename type="first">M</forename><surname>Haugen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Brantsaeter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Trogstad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alexander</forename><forename type="middle">J</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Magnus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Meltzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename></persName>
		</author>
		<idno type="DOI">10.1097/EDE.0b013e3181a70f08</idno>
	</analytic>
	<monogr>
		<title level="j">Epidemiology</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="720" to="726" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension</title>
		<author>
			<persName><forename type="first">F</forename><surname>Herse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lamarca</surname></persName>
		</author>
		<idno type="DOI">10.1111/aji.12072</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Reprod Immunol</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="413" to="418" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Plasma renin substrate and oestrogens in normal pregnancy</title>
		<author>
			<persName><forename type="first">I</forename><surname>Immonen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Siimes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">H</forename><surname>Stenman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kärkkäinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fyhrquist</surname></persName>
		</author>
		<idno type="DOI">10.3109/00365518309168223</idno>
	</analytic>
	<monogr>
		<title level="j">Scand J Clin Lab Invest</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="61" to="65" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Irani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Blackwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Ramin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Kellems</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xia</surname></persName>
		</author>
		<idno type="DOI">10.1084/jem.20090872</idno>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">206</biblScope>
			<biblScope unit="page" from="2809" to="2822" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Prevention of preeclampsia with calcium supplementation and vitamin D3 in an antenatal protocol</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Koyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ohshige</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Maeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yoshimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Okamura</surname></persName>
		</author>
		<idno type="DOI">10.1016/0020-7292%2894%2990350-6</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Gynaecol Obstet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="115" to="120" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia</title>
		<author>
			<persName><forename type="first">B</forename><surname>Lamarca</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Minerva Ginecol</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="309" to="320" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1</title>
		<author>
			<persName><forename type="first">B</forename><surname>Lamarca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Parrish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Ray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Glover</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wallukat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wenzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cockrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Martin</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Ryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dechend</surname></persName>
		</author>
		<idno type="DOI">10.1161/HYPERTENSIONAHA.109.137935</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="905" to="909" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes</title>
		<author>
			<persName><forename type="first">B</forename><surname>Lamarca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wallace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Herse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wallukat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Martin</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Weimer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dechend</surname></persName>
		</author>
		<idno type="DOI">10.1161/HYPERTENSIONAHA.110.167569</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="865" to="871" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Lamarca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>Alexander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Gilbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Ryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sedeek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Granger</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.genm.2008.03.013</idno>
	</analytic>
	<monogr>
		<title level="j">Gend Med</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>Suppl A: S133-S138</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">A longitudinal study of cardiac output in normal human pregnancy</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Mabie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Disessa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Crocker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Sibai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Arheart</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0002-9378%2894%2970297-7</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">170</biblScope>
			<biblScope unit="page" from="849" to="856" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey</title>
		<author>
			<persName><forename type="first">D</forename><surname>Martins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wolf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zadshir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Tareen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Thadhani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Felsenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Levine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mehrotra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Norris</surname></persName>
		</author>
		<idno type="DOI">10.1001/archinte.167.11.1159</idno>
		<idno>doi:10.1001/ archinte.167.11.1159</idno>
	</analytic>
	<monogr>
		<title level="j">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="page" from="1159" to="1165" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Maynard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Min</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Merchan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mondal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Libermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Sellke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">E</forename><surname>Stillman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Epstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">P</forename><surname>Sukhatme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Karumanchi</surname></persName>
		</author>
		<idno type="DOI">10.1172/JCI17189</idno>
		<idno>doi:10.1172/ JCI17189</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="649" to="658" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Lamarca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cockrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Granger</surname></persName>
		</author>
		<idno type="DOI">10.1161/HYPERTENSIONAHA.109.141473</idno>
		<idno>doi:10. 1161/HYPERTENSIONAHA.109.141473</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="394" to="398" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-␣</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Lamarca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Parrish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cockrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Granger</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajpregu.00069.2012</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Regul Integr Comp Physiol</title>
		<imprint>
			<biblScope unit="volume">304</biblScope>
			<biblScope unit="page" from="R130" to="R135" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Elimination of vitamin D receptor in vascular endothelial cells alters vascular function</title>
		<author>
			<persName><forename type="first">W</forename><surname>Ni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">W</forename><surname>Watts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Glenn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Gardner</surname></persName>
		</author>
		<idno type="DOI">10.1161/HYPERTENSIONAHA.114.03971</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="1290" to="1298" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Maternal plasma level of endothelin is increased in preeclampsia</title>
		<author>
			<persName><forename type="first">A</forename><surname>Nova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Sibai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Barton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Mercer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Mitchell</surname></persName>
		</author>
		<idno type="DOI">10.1016/0002-9378%2891%2990317-K</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">165</biblScope>
			<biblScope unit="page" from="724" to="727" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4ϩ T lymphocytes from placental ischemic rats</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Novotny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wallace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Heath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Moseley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dhillon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Weimer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wallukat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Herse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wenzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Martin</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dechend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lamarca</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajpregu.00623.2011</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Regul Integr Comp Physiol</title>
		<imprint>
			<biblScope unit="volume">302</biblScope>
			<biblScope unit="page" from="R1197" to="R1201" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Physiologic changes during normal pregnancy and delivery</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Ouzounian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Elkayam</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ccl.2012.05.004</idno>
	</analytic>
	<monogr>
		<title level="j">Cardiol Clin</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="317" to="329" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Palei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">T</forename><surname>Spradley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Warrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Granger</surname></persName>
		</author>
		<idno type="DOI">10.1111/apha.12106</idno>
		<idno>doi:10.1111/ apha.12106</idno>
	</analytic>
	<monogr>
		<title level="j">Acta Physiol (Oxf)</title>
		<imprint>
			<biblScope unit="volume">208</biblScope>
			<biblScope unit="page" from="224" to="233" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The effect of immune factors, tumor necrosis factor-␣, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Parrish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rutland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wallace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wenzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wallukat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Keiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Ray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dechend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Granger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lamarca</surname></persName>
		</author>
		<idno type="DOI">10.1038/ajh.2010.70</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Hypertens</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="911" to="916" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Endothelin, angiotensin, and oxidative stress in hypertension</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Pollock</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.HYP.0000158262.11935.d0</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="477" to="480" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Goldfien</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hypertens</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="700" to="708" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial</title>
		<author>
			<persName><forename type="first">S</forename><surname>Shab-Bidar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Neyestani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Djazayery</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Eshraghian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Houshiarrad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gharavi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kalayi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Shariatzadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zahedirad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Khalaji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Haidari</surname></persName>
		</author>
		<idno type="DOI">10.1186/1741-7015-9-125</idno>
		<idno>doi:10. 1186/1741-7015-9-125</idno>
	</analytic>
	<monogr>
		<title level="j">BMC Med</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">125</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for pre-eclampsia</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Shand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Nassar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Von</forename><surname>Dadelszen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Innis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Green</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename></persName>
		</author>
		<idno type="DOI">10.1111/j.1471-0528.2010.02742.x</idno>
		<idno>doi:10.1111/ j.1471-0528.2010.02742.x</idno>
	</analytic>
	<monogr>
		<title level="j">BJOG</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="1593" to="1598" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Siddiqui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Irani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Blackwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Ramin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Kellems</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xia</surname></persName>
		</author>
		<idno type="DOI">10.1161/HYPERTENSIONAHA.109.140061</idno>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="386" to="393" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance</title>
		<author>
			<persName><forename type="first">Tam</forename><surname>Tam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">B</forename></persName>
		</author>
		<author>
			<persName><forename type="first">George</forename><forename type="middle">E</forename><surname>Cockrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Arany</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Speed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Lamarca</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Granger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.ajog.2011.01.049</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">204</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia</title>
		<author>
			<persName><forename type="first">R</forename><surname>Thadhani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">P</forename><surname>Mutter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wolf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Levine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">P</forename><surname>Sukhatme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Karumanchi</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2003-031244</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Endocrinol Metab</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="770" to="775" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Hypertension in response to CD4 ϩ T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system</title>
		<author>
			<persName><forename type="first">K</forename><surname>Wallace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Novotny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Heath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Moseley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Martin</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Owens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lamarca</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajpregu.00049.2012</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Regul Integr Comp Physiol</title>
		<imprint>
			<biblScope unit="volume">303</biblScope>
			<biblScope unit="page" from="R144" to="R149" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Miura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Demura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sato</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="2953" to="2962" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Longitudinal vitamin D status in pregnancy and the risk of pre-eclampsia</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Q</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Audibert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hidiroglou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sarafin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Julien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">C</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Fraser</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1471-0528.2012.03307.x</idno>
	</analytic>
	<monogr>
		<title level="j">BJOG</title>
		<imprint>
			<biblScope unit="volume">119</biblScope>
			<biblScope unit="page" from="832" to="839" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Different vitamin D receptor agonists exhibit differential effects on endothelial function and aortic gene expression in 5/6 nephrectomized rats</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Wu-Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">W</forename><surname>Chen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jsbmb.2014.12.002</idno>
	</analytic>
	<monogr>
		<title level="j">J Steroid Biochem Mol Biol</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="page" from="202" to="209" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter</title>
		<author>
			<persName><forename type="first">W</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Szeto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Klopot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.M705495200</idno>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">282</biblScope>
			<biblScope unit="page" from="29821" to="29830" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
